Ascendis Pharma A/S EV/EBIT
Cos'è EV/EBIT di Ascendis Pharma A/S?
EV/EBIT di Ascendis Pharma A/S è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Ascendis Pharma A/S
Cosa fa Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Aziende con ev/ebit simili a Ascendis Pharma A/S
- Surface Transforms Plc ha EV/EBIT di N/A
- Boqii Ltd ha EV/EBIT di N/A
- Sunrun ha EV/EBIT di N/A
- Mind Medicine (MindMed) ha EV/EBIT di N/A
- Coveo Solutions ha EV/EBIT di N/A
- Innovative Designs ha EV/EBIT di N/A
- Ascendis Pharma A/S ha EV/EBIT di N/A
- Biomerica ha EV/EBIT di N/A
- Crescent NV ha EV/EBIT di N/A
- Ivrnet ha EV/EBIT di N/A
- Orion Office REIT ha EV/EBIT di N/A
- Ansal Properties & Infrastructure ha EV/EBIT di N/A
- Nanophase Technologies ha EV/EBIT di N/A